TNF-alpha antagonist therapy modify the tuberculin skin test response.
about
Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients.Assessment of tuberculosis infection during treatment with biologic agents in a BCG-vaccinated pediatric population.Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.Follow-up of 1887 patients receiving tumor necrosis-alpha antagonists: Tuberculin skin test conversion and tuberculosis risk.
P2860
TNF-alpha antagonist therapy modify the tuberculin skin test response.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@en
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@nl
type
label
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@en
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@nl
prefLabel
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@en
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@nl
P2093
P2860
P1476
TNF-alpha antagonist therapy modify the tuberculin skin test response.
@en
P2093
Munevver Mertsoylu
Penbe Cagatay
Reyhan Yildiz
Sevil Kamali
Tulin Cagatay
Zeki Kilicaslan
Ziya Gulbaran
P2860
P2888
P304
P356
10.1007/S00296-010-1424-3
P577
2010-03-27T00:00:00Z